| Title | Author(s) | Year | View Count |  | Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay | Libbrecht, E; Doutreloigne, J; Van De Velde, H; Yuen, MF; Lai, CL; Shapiro, F; Sablon, E | 2007 | 61 |
| Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B | Yuan, HJ; KaHo Wong, D; Doutreloigne, J; Sablon, E; Lai, CL; Yuen, MF | 2007 | 287 |
 | Significance of HBV DNA, core promoter/precore mutations, genotypes, specific sequences of polymerase gene on three-year lamivudine treatment: A predictive model for antiviral therapy | Yuen, RMF; Sablon, E; Libbrecht, E; Van de Velde, H; Wong, DHY; Fung, JYY; Wong, BCY; Lai, CL | 2006 | 79 |
| Significance of viral load, core promoter/precore mutations and specific sequences of polymerase gene in HBV-infected patients on 3-year lamivudine treatment | Yuen, MF; Sablon, E; Libbrecht, E; Van De Velde, H; Wong, DKH; Fung, J; Wong, BCY; Lai, CL | 2006 | 43 |
 | Determinants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearance | Yuan, HJ; Yuen, MF; Wong, DKH; Sum, SM; Doutreloigne, J; Sablon, E; Lai, CL | 2005 | 260 |
| The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B | Yuan, HJ; Yuen, MF; Wong, DKH; Sablon, E; Lai, CL | 2005 | 119 |
| Impact of precore and core promoter mutations on hepatic histology in patients with chronic hepatitis B | Yuan, HJ; Yuen, MF; Wong, DKH; Sum, SM; Sablon, E; Ng, IOL; Lai, CL | 2005 | 102 |
| Long-term follow-up study of Chinese patients with YMDD mutations: Significance of hepatitis B virus genotypes and characteristics of biochemical flares | Yuen, MF; Yuan, HJ; Sablon, E; Wong, DKH; Chan, AOO; Wong, BCY; Lai, CL | 2004 | 241 |
| HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects | Yuen, MF; Wong, DKH; Sablon, E; Tse, E; Ng, IOL; Yuan, HJ; Siu, CW; Sander, TJ; Bourne, EJ; Hall, JG; Condreay, LD; Lai, CL | 2004 | 135 |
| Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong | Yuen, MF; Sablon, E; Tanaka, Y; Kato, T; Mizokami, M; Doutreloigne, J; Yuan, HJ; Wong, DKH; Sum, SM; Lai, CL | 2004 | 111 |
| Erratum: Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation (Clinical Infectious Diseases (August 15, 2003) 37 (593-597)) | Yuen, MF; Sablon, E; Wong, DKH; Yuan, HJ; Wong, BCY; Chan, AOO; Lai, CL | 2004 | 47 |
| Hepatitis B virus genotype A and D clinical outcomes of liver transplantation for HBV-related disease | Girlanda, R; Mohsen, AH; Smith, H; Sablon, E; Yuen, MF; O'grady, J; Muiesan, P; Rela, M; Heaton, N; Norris, S | 2004 | 89 |
| Hepatitis B virus genotype A and D and clinical outcomes of liver transplantation for HBV-related disease | Girlanda, R; Mohsen, A; Smith, H; Sablon, E; Yuen, RMF; O'Grady, J; Muiesan, P; Rela, M; Heaton, N; Norris, S | 2004 | 82 |
| Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine | Yuen, MF; Wong, DKH; Sablon, E; Yuan, HJ; Sum, SM; Hui, CK; Chan, AOO; Wong, BCY; Lai, CL | 2003 | 111 |
| Prognostic factors in severe exacerbation of chronic hepatitis B | Yuen, MF; Sablon, E; Hui, CK; Li, TM; Yuan, HJ; Wong, DKH; Doutreloigne, J; Bogaerts, V; Wong, BCY; Fan, ST; Lai, CL | 2003 | 270 |
| Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation | Yuen, MF; Sablon, E; Wong, DKH; Yuan, HJ; Wong, BCY; Chan, AOO; Lai, CL | 2003 | 279 |
| Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: A comparison with genotype 1 | Hui, CK; Yuen, MF; Sablon, E; Chan, AOO; Wong, BCY; Lai, CL | 2003 | 344 |
| Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma | Yuen, MF; Sablon, E; Yuan, HJ; Wong, DKH; Hui, CK; Wong, BCY; Chan, AOO; Lai, CL | 2003 | 99 |
| Hepatitis B Virus Genotypes B and C Do Not Affect the Anti-viral Response to Lamivudine | Yuen, MF; Wong, DKH; Sablon, E; Yuan, H; Sum, SM; Hui, CK; Wong, BCY; Lai, CL | 2003 | 79 |
| Determinants for the occurrence of acute exacerbation after HBeAg seroclearance in Chinese patients | Yuan, H; Yuen, RMF; Wong, DKH; Sum, SM; Doutreloigne, J; Sablon, E; Lai, CL | 2003 | 76 |
|
